AU Patent

AU565354B2 — Bioadhesive compositions and methods of treatment therewith

Assigned to BioMimetics Inc · Expires 1987-09-10 · 39y expired

What this patent protects

A controlled release treatment composition. The composition includes a bioadhesive and an effective amount of a treating agent. The bioadhesive is a water-swellable, but water-insoluble, fibrous cross-linked carboxy-functional polymer containing a plurality of repeating units of …

USPTO Abstract

A controlled release treatment composition. The composition includes a bioadhesive and an effective amount of a treating agent. The bioadhesive is a water-swellable, but water-insoluble, fibrous cross-linked carboxy-functional polymer containing a plurality of repeating units of which at least about 80 weight percent contain at least one carboxyl functionality.

Drugs covered by this patent

Patent Metadata

Patent number
AU565354B2
Jurisdiction
AU
Classification
—
Expires
1987-09-10
Drug substance claim
No
Drug product claim
No
Assignee
BioMimetics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.